Current progress in non-Edg family LPA receptor research

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1831, Issue 1, 2013, Pages 33-41

  Yanagida, Keisuke ^a   Kurikawa, Yoshitaka ^a   Shimizu, Takao ^a   Ishii, Satoshi ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b AKITA UNIVERSITY   (Japan)

Author keywords

GPR23 p2y9; GPR92 GPR93; LPA4; LPA5; LPA6; p2y5

Indexed keywords

1 OLEOYL 2 O METHYL RAC GLYCEROPHSOPHOTHIONATE; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID 5; LYSOPHOSPHATIDIC ACID RECEPTOR; MESSENGER RNA; UNCLASSIFIED DRUG;

BONE DENSITY; BONE DEVELOPMENT; CELL DIFFERENTIATION; ENANTIOMER; GENE EXPRESSION; HAIR GROWTH; HUMAN; MAST CELL; NEOPLASM; NEUROPATHIC PAIN; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION;

ANIMALS; BIOMEDICAL RESEARCH; DISEASE; HUMANS; LIGANDS; LYSOPHOSPHOLIPIDS; RECEPTORS, LYSOPHOSPHATIDIC ACID; SIGNAL TRANSDUCTION; TERMINOLOGY AS TOPIC;

EID: 84868514597     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2012.08.003     Document Type: Review

References (110)

1. J.W. Choi, D.R. Herr, K. Noguchi, Y.C. Yung, C.W. Lee, T. Mutoh, M.E. Lin, S.T. Teo, K.E. Park, A.N. Mosley, and J. Chun LPA receptors: subtypes and biological actions Annu. Rev. Pharmacol. Toxicol. 50 2010 157 186
2. T. Sano, D. Baker, T. Virag, A. Wada, Y. Yatomi, T. Kobayashi, Y. Igarashi, and G. Tigyi Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood J. Biol. Chem. 277 2002 21197 21206
3. T. Sugiura, S. Nakane, S. Kishimoto, K. Waku, Y. Yoshioka, and A. Tokumura Lysophosphatidic acid, a growth factor-like lipid, in the saliva J. Lipid Res. 43 2002 2049 2055
4. K. Hama, K. Bandoh, Y. Kakehi, J. Aoki, and H. Arai Lysophosphatidic acid (LPA) receptors are activated differentially by biological fluids: possible role of LPA-binding proteins in activation of LPA receptors FEBS Lett. 523 2002 187 192
5. A.M. Tager, P. LaCamera, B.S. Shea, G.S. Campanella, M. Selman, Z. Zhao, V. Polosukhin, J. Wain, B.A. Karimi-Shah, N.D. Kim, W.K. Hart, A. Pardo, T.S. Blackwell, Y. Xu, J. Chun, and A.D. Luster The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak Nat. Med. 14 2008 45 54
6. J. Aoki, A. Inoue, and S. Okudaira Two pathways for lysophosphatidic acid production Biochim. Biophys. Acta 1781 2008 513 518
7. L.A. van Meeteren, P. Ruurs, C. Stortelers, P. Bouwman, M.A. van Rooijen, J.P. Pradere, T.R. Pettit, M.J. Wakelam, J.S. Saulnier-Blache, C.L. Mummery, W.H. Moolenaar, and J. Jonkers Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development Mol. Cell. Biol. 26 2006 5015 5022
8. M. Tanaka, S. Okudaira, Y. Kishi, R. Ohkawa, S. Iseki, M. Ota, S. Noji, Y. Yatomi, J. Aoki, and H. Arai Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid J. Biol. Chem. 281 2006 25822 25830
9. A. Inoue, N. Arima, J. Ishiguro, G.D. Prestwich, H. Arai, and J. Aoki LPA-producing enzyme PA-PLAalpha regulates hair follicle development by modulating EGFR signalling EMBO J. 30 2011 4248 4260
10. J. Chun, T. Hla, K.R. Lynch, S. Spiegel, and W.H. Moolenaar International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature Pharmacol. Rev. 62 2010 579 587
11. J. Chun, E.J. Goetzl, T. Hla, Y. Igarashi, K.R. Lynch, W. Moolenaar, S. Pyne, and G. Tigyi International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature Pharmacol. Rev. 54 2002 265 269
12. H. Ohta, K. Sato, N. Murata, A. Damirin, E. Malchinkhuu, J. Kon, T. Kimura, M. Tobo, Y. Yamazaki, T. Watanabe, M. Yagi, M. Sato, R. Suzuki, H. Murooka, T. Sakai, T. Nishitoba, D.S. Im, H. Nochi, K. Tamoto, H. Tomura, and F. Okajima Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors Mol. Pharmacol. 64 2003 994 1005
13. K. Hama, J. Aoki, M. Fukaya, Y. Kishi, T. Sakai, R. Suzuki, H. Ohta, T. Yamori, M. Watanabe, J. Chun, and H. Arai Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1 J. Biol. Chem. 279 2004 17634 17639
14. J.J. Contos, N. Fukushima, J.A. Weiner, D. Kaushal, and J. Chun Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior Proc. Natl. Acad. Sci. U. S. A. 97 2000 13384 13389
15. J.J. Contos, I. Ishii, N. Fukushima, M.A. Kingsbury, X. Ye, S. Kawamura, J.H. Brown, and J. Chun Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2) Mol. Cell. Biol. 22 2002 6921 6929
16. M.F. Simon, H. Chap, and L. Douste-Blazy Human platelet aggregation induced by 1-alkyl-lysophosphatidic acid and its analogs: a new group of phospholipid mediators? Biochem. Biophys. Res. Commun. 108 1982 1743 1750
17. G. Gueguen, B. Gaige, J.M. Grevy, P. Rogalle, J. Bellan, M. Wilson, A. Klaebe, F. Pont, M.F. Simon, and H. Chap Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation Biochemistry 38 1999 8440 8450
18. A. Tokumura, J. Sinomiya, S. Kishimoto, T. Tanaka, K. Kogure, T. Sugiura, K. Satouchi, K. Waku, and K. Fukuzawa Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids Biochem. J. 365 2002 617 628
19. K. Noguchi, S. Ishii, and T. Shimizu Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family J. Biol. Chem. 278 2003 25600 25606
20. S.M. Pasternack, I. von Kugelgen, K.A. Aboud, Y.A. Lee, F. Ruschendorf, K. Voss, A.M. Hillmer, G.J. Molderings, T. Franz, A. Ramirez, P. Nurnberg, M.M. Nothen, and R.C. Betz G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth Nat. Genet. 40 2008 329 334
21. K. Yanagida, K. Masago, H. Nakanishi, Y. Kihara, F. Hamano, Y. Tajima, R. Taguchi, T. Shimizu, and S. Ishii Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6 J. Biol. Chem. 284 2009 17731 17741
22. M. Lee, S. Choi, G. Hallden, S.J. Yo, D. Schichnes, and G.W. Aponte P2Y5 is a G(alpha)i, G(alpha)12/13 G protein-coupled receptor activated by lysophosphatidic acid that reduces intestinal cell adhesion Am. J. Physiol. Gastrointest. Liver Physiol. 297 2009 G641 G654
23. S. Ishii, K. Noguchi, and K. Yanagida Non-Edg family lysophosphatidic acid (LPA) receptors Prostaglandins Other Lipid Mediat. 89 2009 57 65
24. K. Yanagida, and S. Ishii Non-Edg family LPA receptors: the cutting edge of LPA research J. Biochem. 150 2011 223 232
25. J.H. Hecht, J.A. Weiner, S.R. Post, and J. Chun Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex J. Cell Biol. 135 1996 1071 1083
26. R.M. Sullivan, and S.G. Lucas Fossil squamata from the San-Jose formation, early eocene, San-Juan Basin, New-Mexico J. Paleontol. 62 1998 631
27. K. Bandoh, J. Aoki, H. Hosono, S. Kobayashi, T. Kobayashi, K. Murakami-Murofushi, M. Tsujimoto, H. Arai, and K. Inoue Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid J. Biol. Chem. 274 1999 27776 27785
28. C.W. Lee, R. Rivera, S. Gardell, A.E. Dubin, and J. Chun GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5 J. Biol. Chem. 281 2006 23589 23597
29. K. Kotarsky, A. Boketoft, J. Bristulf, N.E. Nilsson, A. Norberg, S. Hansson, C. Owman, R. Sillard, L.M. Leeb-Lundberg, and B. Olde Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes J. Pharmacol. Exp. Ther. 318 2006 619 628
30. K. Tabata, K. Baba, A. Shiraishi, M. Ito, and N. Fujita The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor Biochem. Biophys. Res. Commun. 363 2007 861 866
31. M. Murakami, A. Shiraishi, K. Tabata, and N. Fujita Identification of the orphan GPCR, P2Y(10) receptor as the sphingosine-1-phosphate and lysophosphatidic acid receptor Biochem. Biophys. Res. Commun. 371 2008 707 712
32. S. Oka, R. Ota, M. Shima, A. Yamashita, and T. Sugiura GPR35 is a novel lysophosphatidic acid receptor Biochem. Biophys. Res. Commun. 395 2010 232 237
33. A. Tokumura A family of phospholipid autacoids: occurrence, metabolism and bioactions Prog. Lipid Res. 34 1995 151 184
34. K. Bandoh, J. Aoki, A. Taira, M. Tsujimoto, H. Arai, and K. Inoue Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors FEBS Lett. 478 2000 159 165
35. W. Vogt Intestine-stimulating activity of various phosphatides and glycolipids Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol. 240 1960 134 139
36. A. Tokumura, K. Fukuzawa, and H. Tsukatani Effects of synthetic and natural lysophosphatidic acids on the arterial blood pressure of different animal species Lipids 13 1978 572 574
37. S. Amisten, O.O. Braun, A. Bengtsson, and D. Erlinge Gene expression profiling for the identification of G-protein coupled receptors in human platelets Thromb. Res. 122 2008 47 57
38. A.L. Khandoga, Y. Fujiwara, P. Goyal, D. Pandey, R. Tsukahara, A. Bolen, H. Guo, N. Wilke, J. Liu, W.J. Valentine, G.G. Durgam, D.D. Miller, G. Jiang, G.D. Prestwich, G. Tigyi, and W. Siess Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin Platelets 19 2008 415 427
39. J.R. Williams, A.L. Khandoga, P. Goyal, J.I. Fells, D.H. Perygin, W. Siess, A.L. Parrill, G. Tigyi, and Y. Fujiwara Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation J. Biol. Chem. 284 2009 17304 17319
40. A.L. Khandoga, D. Pandey, U. Welsch, R. Brandl, and W. Siess GPR92/LPA5 lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaques Cardiovasc. Res. 90 2011 157 164
41. Y. Shimomura Congenital hair loss disorders: rare, but not too rare J. Dermatol. 39 2012 3 10
42. H. Sonoda, J. Aoki, T. Hiramatsu, M. Ishida, K. Bandoh, Y. Nagai, R. Taguchi, K. Inoue, and H. Arai A novel phosphatidic acid-selective phospholipase A1 that produces lysophosphatidic acid J. Biol. Chem. 277 2002 34254 34263
43. T. Sugiura, A. Tokumura, L. Gregory, T. Nouchi, S.T. Weintraub, and D.J. Hanahan Biochemical characterization of the interaction of lipid phosphoric acids with human platelets: comparison with platelet activating factor Arch. Biochem. Biophys. 311 1994 358 368
44. C.E. Heise, W.L. Santos, A.M. Schreihofer, B.H. Heasley, Y.V. Mukhin, T.L. Macdonald, and K.R. Lynch Activity of 2-substituted lysophosphatidic acid (LPA) analogs at LPA receptors: discovery of a LPA1/LPA3 receptor antagonist Mol. Pharmacol. 60 2001 1173 1180
45. B.H. Heasley, R. Jarosz, K.R. Lynch, and T.L. Macdonald Initial structure-activity relationships of lysophosphatidic acid receptor antagonists: discovery of a high-affinity LPA1/LPA3 receptor antagonist Bioorg. Med. Chem. Lett. 14 2004 2735 2740
46. W.L. Santos, B.H. Heasley, R. Jarosz, K.M. Carter, K.R. Lynch, and T.L. Macdonald Synthesis and biological evaluation of phosphonic and thiophosphoric acid derivatives of lysophosphatidic acid Bioorg. Med. Chem. Lett. 14 2004 3473 3476
47. B.H. Heasley, R. Jarosz, K.M. Carter, S.J. Van, K.R. Lynch, and T.L. Macdonald A novel series of 2-pyridyl-containing compounds as lysophosphatidic acid receptor antagonists: development of a nonhydrolyzable LPA3 receptor-selective antagonist Bioorg. Med. Chem. Lett. 14 2004 4069 4074
48. L. Qian, Y. Xu, Y. Hasegawa, J. Aoki, G.B. Mills, and G.D. Prestwich Enantioselective responses to a phosphorothioate analogue of lysophosphatidic acid with LPA3 receptor-selective agonist activity J. Med. Chem. 46 2003 5575 5578
49. Y. Hasegawa, J.R. Erickson, G.J. Goddard, S. Yu, S. Liu, K.W. Cheng, A. Eder, K. Bandoh, J. Aoki, R. Jarosz, A.D. Schrier, K.R. Lynch, G.B. Mills, and X. Fang Identification of a phosphothionate analogue of lysophosphatidic acid (LPA) as a selective agonist of the LPA3 receptor J. Biol. Chem. 278 2003 11962 11969
50. L. Qian, Y. Xu, T. Simper, G. Jiang, J. Aoki, M. Umezu-Goto, H. Arai, S. Yu, G.B. Mills, R. Tsukahara, N. Makarova, Y. Fujiwara, G. Tigyi, and G.D. Prestwich Phosphorothioate analogues of alkyl lysophosphatidic acid as LPA3 receptor-selective agonists ChemMedChem 1 2006 376 383
51. M.D. Okusa, H. Ye, L. Huang, L. Sigismund, T. Macdonald, and K.R. Lynch Selective blockade of lysophosphatidic acid LPA3 receptors reduces murine renal ischemia-reperfusion injury Am. J. Physiol. Renal Physiol. 285 2003 F565 F574
52. D.A. Lin, and J.A. Boyce IL-4 regulates MEK expression required for lysophosphatidic acid-mediated chemokine generation by human mast cells J. Immunol. 175 2005 5430 5438
53. M.M. Murph, J. Hurst-Kennedy, V. Newton, D.N. Brindley, and H. Radhakrishna Lysophosphatidic acid decreases the nuclear localization and cellular abundance of the p53 tumor suppressor in A549 lung carcinoma cells Mol. Cancer Res. 5 2007 1201 1211
54. C. Zhao, M.J. Fernandes, G.D. Prestwich, M. Turgeon, J. Di Battista, T. Clair, P.E. Poubelle, and S.G. Bourgoin Regulation of lysophosphatidic acid receptor expression and function in human synoviocytes: implications for rheumatoid arthritis? Mol. Pharmacol. 73 2008 587 600
55. Z. Zhou, J. Niu, and Z. Zhang The role of lysophosphatidic acid receptors in phenotypic modulation of vascular smooth muscle cells Mol. Biol. Rep. 37 2010 2675 2686
56. J.P. Mansell, M. Barbour, C. Moore, M. Nowghani, M. Pabbruwe, T. Sjostrom, and A.W. Blom The synergistic effects of lysophosphatidic acid receptor agonists and calcitriol on MG63 osteoblast maturation at titanium and hydroxyapatite surfaces Biomaterials 31 2010 199 206
57. J.W. Lee, C.H. Kim, Y.Y. Wang, X.M. Yan, and U.D. Sohn Lysophosphatidic acid presynaptically blocks NO uptake during electric field stimulation-induced relaxation via LPA(1) receptor in cat lower esophageal sphincter Arch. Pharm. Res. 34 2011 169 176
58. D.J. Fischer, N. Nusser, T. Virag, K. Yokoyama, D. Wang, D.L. Baker, D. Bautista, A.L. Parrill, and G. Tigyi Short-chain phosphatidates are subtype-selective antagonists of lysophosphatidic acid receptors Mol. Pharmacol. 60 2001 776 784
59. G.G. Durgam, R. Tsukahara, N. Makarova, M.D. Walker, Y. Fujiwara, K.R. Pigg, D.L. Baker, V.M. Sardar, A.L. Parrill, G. Tigyi, and D.D. Miller Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands Bioorg. Med. Chem. Lett. 16 2006 633 640
60. K. Liliom, T. Tsukahara, R. Tsukahara, M. Zelman-Femiak, E. Swiezewska, and G. Tigyi Farnesyl phosphates are endogenous ligands of lysophosphatidic acid receptors: inhibition of LPA GPCR and activation of PPARs Biochim. Biophys. Acta 1761 2006 1506 1514
61. D.Y. Oh, J.M. Yoon, M.J. Moon, J.I. Hwang, H. Choe, J.Y. Lee, J.I. Kim, S. Kim, H. Rhim, D.K. O'Dell, J.M. Walker, H.S. Na, M.G. Lee, H.B. Kwon, K. Kim, and J.Y. Seong Identification of farnesyl pyrophosphate and N-arachidonylglycine as endogenous ligands for GPR92 J. Biol. Chem. 283 2008 21054 21064
62. M. Komachi, K. Sato, M. Tobo, C. Mogi, T. Yamada, H. Ohta, H. Tomura, T. Kimura, D.S. Im, K. Yanagida, S. Ishii, I. Takeyoshi, and F. Okajima Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo Cancer Sci. 103 2012 1099 1104
63. C.W. Lee, R. Rivera, A.E. Dubin, and J. Chun LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation J. Biol. Chem. 282 2007 4310 4317
64. J.S. Swaney, C. Chapman, L.D. Correa, K.J. Stebbins, R.A. Bundey, P.C. Prodanovich, P. Fagan, C.S. Baccei, A.M. Santini, J.H. Hutchinson, T.J. Seiders, T.A. Parr, P. Prasit, J.F. Evans, and D.S. Lorrain A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model Br. J. Pharmacol. 160 2010 1699 1713
65. Y. Takuwa, N. Takuwa, and N. Sugimoto The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities J. Biochem. 131 2002 767 771
66. K. Yanagida, S. Ishii, F. Hamano, K. Noguchi, and T. Shimizu LPA4/p2y9/GPR23 mediates rho-dependent morphological changes in a rat neuronal cell line J. Biol. Chem. 282 2007 5814 5824
67. Z. Lee, C.T. Cheng, H. Zhang, M.A. Subler, J. Wu, A. Mukherjee, J.J. Windle, C.K. Chen, and X. Fang Role of LPA4/p2y9/GPR23 in negative regulation of cell motility Mol. Biol. Cell 19 2008 5435 5445
68. H. Sumida, K. Noguchi, Y. Kihara, M. Abe, K. Yanagida, F. Hamano, S. Sato, K. Tamaki, Y. Morishita, M.R. Kano, C. Iwata, K. Miyazono, K. Sakimura, T. Shimizu, and S. Ishii LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis Blood 116 2010 5060 5070
69. S. Offermanns, V. Mancino, J.P. Revel, and M.I. Simon Vascular system defects and impaired cell chemokinesis as a result of Galpha13 deficiency Science 275 1997 533 536
70. J.L. Gu, S. Muller, V. Mancino, S. Offermanns, and M.I. Simon Interaction of G alpha(12) with G alpha(13) and G alpha(q) signaling pathways Proc. Natl. Acad. Sci. U. S. A. 99 2002 9352 9357
71. K.M. Ruppel, D. Willison, H. Kataoka, A. Wang, Y.W. Zheng, I. Cornelissen, L. Yin, S.M. Xu, and S.R. Coughlin Essential role for Galpha13 in endothelial cells during embryonic development Proc. Natl. Acad. Sci. U. S. A. 102 2005 8281 8286
72. K. Harper, D. Arsenault, S. Boulay-Jean, A. Lauzier, F. Lucien, and C.M. Dubois Autotaxin promotes cancer invasion via the lysophosphatidic acid receptor 4: participation of the cyclic AMP/EPAC/Rac1 signaling pathway in invadopodia formation Cancer Res. 70 2010 4634 4643
73. Y.B. Liu, Y. Kharode, P.V. Bodine, P.J. Yaworsky, J.A. Robinson, and J. Billiard LPA induces osteoblast differentiation through interplay of two receptors: LPA1 and LPA4 J. Cell. Biochem. 109 2010 794 800
74. Y. Daaka, L.M. Luttrell, and R.J. Lefkowitz Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A Nature 390 1997 88 91
75. S. Mittra, and J.P. Bourreau Gs and Gi coupling of adrenomedullin in adult rat ventricular myocytes Am. J. Physiol. Heart Circ. Physiol. 290 2006 H1842 H1847
76. M. Jongsma, E. Matas-Rico, A. Rzadkowski, K. Jalink, and W.H. Moolenaar LPA is a chemorepellent for B16 melanoma cells: action through the cAMP-elevating LPA5 receptor PLoS One 6 2012 e29260
77. S. Choi, M. Lee, A.L. Shiu, S.J. Yo, and G.W. Aponte Identification of a protein hydrolysate responsive G protein-coupled receptor in enterocytes Am. J. Physiol. Gastrointest. Liver Physiol. 292 2007 G98 G112
78. A. Lundequist, and J.A. Boyce LPA5 is abundantly expressed by human mast cells and important for lysophosphatidic acid induced MIP-1beta release PLoS One 6 2011 e18192
79. S. Koike, K. Keino-Masu, T. Ohto, F. Sugiyama, S. Takahashi, and M. Masu Autotaxin/lysophospholipase D-mediated lysophosphatidic acid signaling is required to form distinctive large lysosomes in the visceral endoderm cells of the mouse yolk sac J. Biol. Chem. 284 2009 33561 33570
80. S. Fotopoulou, N. Oikonomou, E. Grigorieva, I. Nikitopoulou, T. Paparountas, A. Thanassopoulou, Z. Zhao, Y. Xu, D.L. Kontoyiannis, E. Remboutsika, and V. Aidinis ATX expression and LPA signalling are vital for the development of the nervous system Dev. Biol. 339 2010 451 464
81. G. Ferry, A. Giganti, F. Coge, F. Bertaux, K. Thiam, and J.A. Boutin Functional invalidation of the autotaxin gene by a single amino acid mutation in mouse is lethal FEBS Lett. 581 2007 3572 3578
82. X. Ye, K. Hama, J.J. Contos, B. Anliker, A. Inoue, M.K. Skinner, H. Suzuki, T. Amano, G. Kennedy, H. Arai, J. Aoki, and J. Chun LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing Nature 435 2005 104 108
83. X. Ye, M.K. Skinner, G. Kennedy, and J. Chun Age-dependent loss of sperm production in mice via impaired lysophosphatidic acid signaling Biol. Reprod. 79 2008 328 336
84. H. Yukiura, K. Hama, K. Nakanaga, M. Tanaka, Y. Asaoka, S. Okudaira, N. Arima, A. Inoue, T. Hashimoto, H. Arai, A. Kawahara, H. Nishina, and J. Aoki Autotaxin regulates vascular development via multiple lysophosphatidic acid (LPA) receptors in zebrafish J. Biol. Chem. 286 2011 43972 43983
85. S.J. Lee, T.H. Chan, T.C. Chen, B.K. Liao, P.P. Hwang, and H. Lee LPA1 is essential for lymphatic vessel development in zebrafish FASEB J. 22 2008 3706 3715
86. I. Gennero, S. Laurencin-Dalicieux, F. Conte-Auriol, F. Briand-Mesange, D. Laurencin, J. Rue, N. Beton, N. Malet, M. Mus, A. Tokumura, P. Bourin, L. Vico, G. Brunel, R.O. Oreffo, J. Chun, and J.P. Salles Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass Bone 49 2011 395 403
87. J. Blackburn, and J.P. Mansell The emerging role of lysophosphatidic acid (LPA) in skeletal biology Bone 50 2012 756 762
88. S. Bagga, K.S. Price, D.A. Lin, D.S. Friend, K.F. Austen, and J.A. Boyce Lysophosphatidic acid accelerates the development of human mast cells Blood 104 2004 4080 4087
89. T. Hashimoto, H. Ohata, and K. Honda Lysophosphatidic acid (LPA) induces plasma exudation and histamine release in mice via LPA receptors J. Pharmacol. Sci. 100 2006 82 87
90. T. Hashimoto, H. Ohata, K. Momose, and K. Honda Lysophosphatidic acid induces histamine release from mast cells and skin fragments Pharmacology 75 2005 13 20
91. T. Hashimoto, H. Ohata, and K. Momose Itch-scratch responses induced by lysophosphatidic acid in mice Pharmacology 72 2004 51 56
92. K. Mori, J. Kitayama, J. Aoki, Y. Kishi, D. Shida, H. Yamashita, H. Arai, and H. Nagawa Submucosal connective tissue-type mast cells contribute to the production of lysophosphatidic acid (LPA) in the gastrointestinal tract through the secretion of autotaxin (ATX)/lysophospholipase D (lysoPLD) Virchows Arch. 451 2007 47 56
93. M.L. Stracke, H.C. Krutzsch, E.J. Unsworth, A. Arestad, V. Cioce, E. Schiffmann, and L.A. Liotta Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein J. Biol. Chem. 267 1992 2524 2529
94. M. Umezu-Goto, Y. Kishi, A. Taira, K. Hama, N. Dohmae, K. Takio, T. Yamori, G.B. Mills, K. Inoue, J. Aoki, and H. Arai Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production J. Cell Biol. 158 2002 227 233
95. G.B. Mills, and W.H. Moolenaar The emerging role of lysophosphatidic acid in cancer Nat. Rev. Cancer 3 2003 582 591
96. W.H. Moolenaar, L.A. van Meeteren, and B.N. Giepmans The ins and outs of lysophosphatidic acid signaling Bioessays 26 2004 870 881
97. X. Xu, G. Yang, H. Zhang, and G.D. Prestwich Evaluating dual activity LPA receptor pan-antagonist/autotaxin inhibitors as anti-cancer agents in vivo using engineered human tumors Prostaglandins Other Lipid Mediat. 89 2009 140 146
98. D.L. Baker, Y. Fujiwara, K.R. Pigg, R. Tsukahara, S. Kobayashi, H. Murofushi, A. Uchiyama, K. Murakami-Murofushi, E. Koh, R.W. Bandle, H.S. Byun, R. Bittman, D. Fan, M. Murph, G.B. Mills, and G. Tigyi Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis J. Biol. Chem. 281 2006 22786 22793
99. M.K. Altman, V. Gopal, W. Jia, S. Yu, H. Hall, G.B. Mills, A.C. McGinnis, M.G. Bartlett, G. Jiang, D. Madan, G.D. Prestwich, Y. Xu, M.A. Davies, and M.M. Murph Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid Mol. Cancer 9 2010 140
100. R. Gupte, A. Siddam, Y. Lu, W. Li, Y. Fujiwara, N. Panupinthu, T.C. Pham, D.L. Baker, A.L. Parrill, M. Gotoh, K. Murakami-Murofushi, S. Kobayashi, G.B. Mills, G. Tigyi, and D.D. Miller Synthesis and pharmacological evaluation of the stereoisomers of 3-carba cyclic-phosphatidic acid Bioorg. Med. Chem. Lett. 20 2010 7525 7528
101. R. Gupte, R. Patil, J. Liu, Y. Wang, S.C. Lee, Y. Fujiwara, J. Fells, A.L. Bolen, K. Emmons-Thompson, C.R. Yates, A. Siddam, N. Panupinthu, T.C. Pham, D.L. Baker, A.L. Parrill, G.B. Mills, G. Tigyi, and D.D. Miller Benzyl and naphthalene methylphosphonic acid inhibitors of autotaxin with anti-invasive and anti-metastatic activity ChemMedChem 6 2011 922 935
102. H. Ueda Lysophosphatidic acid as the initiator of neuropathic pain Biol. Pharm. Bull. 34 2011 1154 1158
103. M. Inoue, L. Ma, J. Aoki, J. Chun, and H. Ueda Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain Mol. Pain 4 2008 6
104. M. Inoue, M.H. Rashid, R. Fujita, J.J. Contos, J. Chun, and H. Ueda Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling Nat. Med. 10 2004 712 718
105. L. Ma, H. Uchida, J. Nagai, M. Inoue, J. Chun, J. Aoki, and H. Ueda Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain Mol. Pain 5 2009 64
106. M.E. Lin, R.R. Rivera, and J. Chun Targeted deletion of LPA5 identifies novel roles for LPA signaling in the development of neuropathic pain J. Biol. Chem. 287 2012 17608 17617
107. T. Takahashi, A. Kamimura, T. Hamazono-Matsuoka, and S. Honda Phosphatidic acid has a potential to promote hair growth in vitro and in vivo, and activates mitogen-activated protein kinase/extracellular signal-regulated kinase kinase in hair epithelial cells J. Invest. Dermatol. 121 2003 448 456
108. A. Kazantseva, A. Goltsov, R. Zinchenko, A.P. Grigorenko, A.V. Abrukova, Y.K. Moliaka, A.G. Kirillov, Z. Guo, S. Lyle, E.K. Ginter, and E.I. Rogaev Human hair growth deficiency is linked to a genetic defect in the phospholipase gene LIPH Science 314 2006 982 985
109. Y. Shimomura, M. Wajid, Y. Ishii, L. Shapiro, L. Petukhova, D. Gordon, and A.M. Christiano Disruption of P2RY5, an orphan G protein-coupled receptor, underlies autosomal recessive woolly hair Nat. Genet. 40 2008 335 339
110. S. Basit, G. Ali, N. Wasif, M. Ansar, and W. Ahmad Genetic mapping of a novel hypotrichosis locus to chromosome 7p21.3-p22.3 in a Pakistani family and screening of the candidate genes Hum. Genet. 128 2010 213 220